COVID-19 and MS
Last updated: 30/04/21
Last reviewed: 30/04/21
COVID-19 and MS
These pages contain information about COVID-19, vaccinations and MS as general advice only. The information provided as outlined above is displayed on the MS Australia website. MS Research Australia and MS Australia have worked collaboratively to produce this information on COVID-19 and MS, however this information should not be taken as individual medical advice. Your medical team (Neurologist, MS specialist health care team, GP) is still your primary source of contact for any concerns or specific questions you may have about COVID-19, vaccinations and timing of MS treatments and other medicines.
For general queries, please contact your state/territory MS organisation, or the Coronavirus Hotline on 1800 675 398.
At MS Research Australia and MS Australia, we remain committed to providing the MS community with updated and current information regarding COVID-19 and vaccinations as it becomes readily available, including the regular review of these web pages. The organisational guidance documents we recommend reading for people and families living with MS comes from several reputable sources. These include:
- A group of local neurologists with a special interest in MS through the Australian and New Zealand Association of Neurologists (ANZAN)
- An international MS group, led by the Multiple Sclerosis International Federation (MSIF)
- MS Research Australia together with the ANZAN MS group have provided COVID-19 vaccination guidance addressing many common questions about the vaccination process and living with MS through the vaccination roll-out across the country
If you still have questions that are not answered in these resources, please contact your neurologist, MS specialist health care team or your GP. Together we can build on the extensive information we already have gained through the COVID-19 pandemic and continue to help people and families living with MS to live their best lives possible as we navigate this new world.
How you can help experts around the world in learning more about COVID-19 and MS
As the COVID-19 pandemic and vaccination roll-out remain global health priorities, collecting, sharing and analysing data from all around the world is more important than ever. This data sharing initiative means we will gain faster and more accurate insights into COVID-19 and MS, to help people with MS and their health care teams make evidence-based decisions on how to manage their condition during the pandemic, how to manage the illness if they develop a COVID-19 infection and how to manage the COVID-19 vaccination process.